Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA). (2020)

First Author: Collyer BS
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pntd.0008644

PubMed Identifier: 33044958

Publication URI: http://europepmc.org/abstract/MED/33044958

Type: Journal Article/Review

Volume: 14

Parent Publication: PLoS neglected tropical diseases

Issue: 10

ISSN: 1935-2727